CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net income	$ 37,193	$ 19,581	$ 20,853
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,979	15,421	13,780
Provision for losses on accounts receivable	2,198	2,098	1,679
Stock-based compensation expense	3,162	3,229	4,444
Deferred income tax expense (benefit)	(11,651)	4,855	3,035
Amortization of deferred financing costs	820	824	921
Accretion of discount on convertible subordinated notes	4,329	3,870	3,454
Loss on early extinguishment of debt	0	567	0
Net (gain) loss on sale of businesses and disposal of other assets	(710)	2,077	(49)
Impairment of intangible assets	0	145	0
Changes in operating assets and liabilities that provided (required) cash:
Accounts and preneed receivables	(4,254)	(5,162)	(2,310)
Inventories and other current assets	1,446	1,995	2,582
Intangible and other non-current assets	149	(1,155)	150
Preneed funeral and cemetery trust investments	(10,008)	(14,528)	25,543
Accounts payable	(3,649)	2,112	1,445
Accrued and other liabilities	(385)	780	2,091
Deferred preneed funeral and cemetery revenue	1,446	(640)	329
Deferred preneed funeral and cemetery receipts held in trust	9,165	13,966	(26,461)
Net cash provided by operating activities	45,230	50,035	51,486
Cash flows from investing activities:
Acquisitions and land for new construction	(28,799)	(26,556)	(9,725)
Purchase of land and buildings previously leased	0	(6,258)	(6,080)
Net proceeds from sale of businesses and other assets	5,731	4,385	65
Capital expenditures	(16,395)	(16,846)	(29,744)
Net cash used in investing activities	(39,463)	(45,275)	(45,484)
Cash flows from financing activities:
Borrowings from the revolving credit facility	106,900	71,200	103,600
Payments against the revolving credit facility	(82,600)	(96,100)	(51,500)
Borrowings from the term loan	0	39,063	1,562
Payments against the term loan	(11,250)	(11,250)	(10,937)
Payments on long-term debt and obligations under capital leases	(1,962)	(1,789)	(1,014)
Payments on contingent consideration recorded at acquisition date	(101)	0	0
Proceeds from the exercise of stock options and employee stock purchase plan contributions	1,496	870	758
Taxes paid on restricted stock vestings and exercises of non-qualified options	(509)	(578)	(1,582)
Dividends paid on common stock	(3,709)	(2,492)	(1,819)
Payment of loan origination costs related to the credit facility	0	(717)	(13)
Purchase of treasury stock	(16,366)	0	(44,999)
Excess tax benefit (deficiency) of equity compensation	0	(216)	64
Net cash used in financing activities	(8,101)	(2,009)	(5,880)
Net (decrease) increase in cash and cash equivalents	(2,334)	2,751	122
Cash and cash equivalents at beginning of year	3,286	535	413
Cash and cash equivalents at end of year	$ 952	$ 3,286	$ 535